News | December 17, 2025
Bristol Myers Squibb launches AI-powered ‘Mosaic’ hub in Mumbai
India plays a critical role in Bristol Myers Squibb’s global strategy
India plays a critical role in Bristol Myers Squibb’s global strategy
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
It's a development that marks a potential breakthrough for people living with the rare and debilitating disease Duchenne muscular dystrophy (DMD)
Here's a development that aims to keep your blood pressure in check. Literally!
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
Subscribe To Our Newsletter & Stay Updated
